MUV2:XETRMunchener Ruckversicherungs-Gesellschaft AG Analysis
Data as of 2026-06-07 - not real-time
€448.10
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: MUV2 trades at €448.1, well below its 20‑day (€465.4), 50‑day (€510.4) and 200‑day (€531.1) moving averages, signaling a bearish trend. The RSI sits at 31.9 (oversold) and the MACD remains bearish, while volume is decreasing and 30‑day volatility is high at ~29%. The price is just above the nearest support (€437.4) with resistance near €505.2.
Fundamental perspective: The stock appears markedly undervalued – a trailing P/E of 8.6 versus the industry average of 17, a price‑to‑book of 1.66 and a dividend yield of 5.36% supported by a modest 38% payout ratio. ROE is strong at ~20% and net debt is manageable (debt €7.5bn vs cash €5.6bn). Analyst consensus targets around €551 suggest ~23% upside, though the consensus recommendation remains “hold”.
Fundamental perspective: The stock appears markedly undervalued – a trailing P/E of 8.6 versus the industry average of 17, a price‑to‑book of 1.66 and a dividend yield of 5.36% supported by a modest 38% payout ratio. ROE is strong at ~20% and net debt is manageable (debt €7.5bn vs cash €5.6bn). Analyst consensus targets around €551 suggest ~23% upside, though the consensus recommendation remains “hold”.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bearish momentum
- High short‑term volatility and declining volume
- Attractive dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervaluation relative to peers (P/E 8.6 vs 17)
- Analyst price targets imply ~23% upside
- Strong ROE and sustainable dividend support earnings growth
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Durable business model in global reinsurance and specialty insurance
- Consistent profitability and solid balance sheet
- High, sustainable dividend yield enhances total return over time
Key Metrics & Analysis
Financial Health
Revenue Growth-6.00%
Profit Margin10.97%
P/E Ratio8.6
ROE19.85%
ROA2.27%
Debt/Equity21.72
P/B Ratio1.7
Industry P/E17.0
Technical Analysis
TrendBearish
RSI31.9
Support€437.40
Resistance€505.20
MA 20€465.36
MA 50€510.40
MA 200€531.15
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Target Price€551.19
Upside/Downside23.01%
GradeUndervalued
TypeValue
Dividend Yield5.36%
Risk Assessment
Beta0.24
Volatility29.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.